Early phase clinical trial units (EPCTU)
Active Awarded Last action
- Contract number
- 75N93022D00018
- Awardee
-
Icon Government And Public Health Solutions, Inc. UEI JHJ7HXD5XR47
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $5,339,105 obligated
Award facts
- Opportunity
-
- Early Phase Clinical Trial Units (EPCTU) Pre-Solicitation · 75N93020R00023 · Posted Nov 19, 2020
- Combined order value
-
- $5,339,105 Current, with exercised options
- $6,163,569 Potential, with all options
- Last date to order 48% complete
- IDV ceiling 2% used
- $346,610,277.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $346.6 million multiple-award Indefinite Delivery/Indefinite Quantity contract to Icon Government and Public Health Solutions, Inc. for Early Phase Clinical Trial Units (EPCTU) services. The contract, awarded January 14, 2022, with an ultimate completion date of January 13, 2032, encompasses a seven-year ordering period supporting Phase 0 through Phase III clinical trials of investigational infectious disease products. Icon, a foreign-owned clinical research services provider headquartered in Blue Bell, Pennsylvania, delivers comprehensive end-to-end clinical trial support including protocol development, regulatory submissions, study execution, site selection, participant recruitment, and data management. The contract utilizes no set-aside designation, indicating open competition among eligible contractors.
Task orders issued under the EPCTU vehicle demonstrate the breadth of clinical trial activities being procured. Specific deliverables include Phase I healthy volunteer studies and Phase I special population studies, exemplified by a $2.51 million cost-plus-fixed-fee delivery order for a Phase 1 trial evaluating a genetically modified probiotic yeast therapeutic for Clostridioides difficile infection, and a $2.02 million delivery order for Phase I clinical research services performed in Hinckley, Ohio. Work is being performed at multiple domestic locations, including Hinckley, Ohio and Penllyn, Pennsylvania. The contract structure enables NIAID to rapidly issue task orders to support its portfolio of early-stage investigational products targeting infectious diseases and public health threats, with pricing structured as cost-plus-fixed-fee arrangements that allow for flexible execution of diverse clinical research initiatives across the specified seven-year performance period.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 11
Quick answers
Who was awarded contract 75N93022D00018?
75N93022D00018 was awarded to Icon Government And Public Health Solutions, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 14, 2022.
How much is contract 75N93022D00018 worth?
Orders under 75N93022D00018 have obligated $5,339,105. Their combined potential value, with all options, is $6,163,569. 75N93022D00018's own ceiling is $346,610,277.
How many orders have been placed under contract 75N93022D00018?
3 orders have been placed under 75N93022D00018, the latest on July 5, 2023.
Who can order from contract 75N93022D00018?
75N93022D00018 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93022D00018 part of a contract vehicle?
Yes. 75N93022D00018 is part of Early Phase Clinical Trial Units (EPCTU).
Was contract 75N93022D00018 competed?
The extent of competition for 75N93022D00018 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV